E193 E193 (Zonisamide 25 mg)
Pill imprint E193 E193 has been identified as Zonisamide 25 mg.
Zonisamide is used in the treatment of migraine prevention; seizures; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- E193 E193
- Strength:
- 25 mg
- Color:
- Orange / Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0193
- Inactive Ingredients:
- microcrystalline cellulose
ferrosoferric oxide
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
hydrogenated castor oil
sodium lauryl sulfate
titanium dioxide
More about zonisamide
Consumer resources
- Other brands: Zonegran
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
